Quest Diagnostics Inc (DGX) Shares outstanding analysis
- Shares outstanding · latest quarter: Value 110.37M; Formula and calculation Own reported common class count; original count date 2026-06-30. Comparisons require matching class and complete dated split coverage..
- Shares outstanding · 1 year ago: Value (m); Formula and calculation Own reported common class count; original count date 2026-06-30. Comparisons require matching class and complete dated split coverage..
- Shares outstanding · 5 years ago: Value (m); Formula and calculation Own reported common class count; original count date 2026-06-30. Comparisons require matching class and complete dated split coverage..
- Shares change · vs previous quarter: Value (m); Formula and calculation Own reported common class count; original count date 2026-06-30. Comparisons require matching class and complete dated split coverage..
Shares outstanding analysis
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Shares outstanding · latest quarter | 110.37M | Own reported common class count; original count date 2026-06-30. Comparisons require matching class and complete dated split coverage. |
| Shares outstanding · 1 year ago | (m) | Own reported common class count; original count date 2026-06-30. Comparisons require matching class and complete dated split coverage. |
| Shares outstanding · 5 years ago | (m) | Own reported common class count; original count date 2026-06-30. Comparisons require matching class and complete dated split coverage. |
| Shares change · vs previous quarter | (m) | Own reported common class count; original count date 2026-06-30. Comparisons require matching class and complete dated split coverage. Calculation unavailable: missing inputs remain (m). |
| Shares count change · vs previous quarter | (m) | Own reported common class count; original count date 2026-06-30. Comparisons require matching class and complete dated split coverage. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Current quarter shares | 110.37M shares | |
| Previous quarter shares | (m) |
Shares means common shares outstanding, adjusted to the same split basis for comparison. It is a count, not USD or convertible securities; B means billion shares.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Current quarter shares (shares) | Shares count change · vs previous quarter | Shares change (%) · vs previous quarter |
|---|---|---|---|
| 2026-06-30 | 110.37M | (m) | (m) |
| 2026-03-31 | 110.70M | (m) | (m) |
| 2025-12-31 | 109.87M | (m) | (m) |
| 2025-09-30 | 111.24M | (m) | (m) |
| 2025-06-30 | 111.82M | (m) | (m) |
| 2025-03-31 | 111.64M | (m) | (m) |
| 2024-12-31 | 110.98M | (m) | (m) |
| 2024-09-30 | 111.62M | (m) | (m) |
| 2024-06-30 | 111.32M | (m) | (m) |
| 2024-03-31 | 111.09M | (m) | (m) |
| 2023-12-31 | 110.71M | (m) | (m) |
| 2023-09-30 | 112.43M | (m) | (m) |
| 2023-06-30 | 112.23M | (m) | (m) |
| 2023-03-31 | 112.01M | (m) | (m) |
| 2022-12-31 | 111.32M | (m) | (m) |
| 2022-09-30 | 113.89M | (m) | (m) |
| 2022-06-30 | 116.61M | (m) | (m) |
| 2022-03-31 | 117.37M | (m) | (m) |
| 2021-12-31 | 119.45M | (m) | (m) |
| 2021-09-30 | 122.67M | (m) | (m) |
| 2021-06-30 | 122.18M | (m) | (m) |
| 2021-03-31 | 130.64M | (m) | (m) |
| 2020-12-31 | 133.45M | (m) | (m) |
| 2020-09-30 | 134.77M | (m) | (m) |
| 2020-06-30 | 134.30M | (m) | (m) |
| 2020-03-31 | 133.73M | (m) | (m) |
| 2019-12-31 | 133.46M | (m) | (m) |
| 2019-06-30 | 134.67M | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LABCORP HOLDINGS INC. (LH) | United States | $25.060B | 22.60 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |